… of imiquimod for the treatment of genital warts … imiquimod may attract more T cells elicited
by a therapeutic vaccine, and therefore may better eliminate HPV infected KCs of genital warts…

… The evidence base for imiquimod in treating genital warts is of high quality and the necessary
size from which to draw useful conclusions. Imiquimod is effective in home application, …

… Patient applied 5% imiquimod cream was more effective compared to 1… imiquimod 5%
cream for external anogenital warts was 3 times per week. In placebo controlled trials, imiquimod …

… the effectiveness and safety of imiquimod compared to placebo and any other patient‐applied
or provider‐administered therapy for treatment of anogenital warts (AGW) in adults without …

… warts occurred in 37 to 50% of immunocompetent patients with genital warts treated with
imiquimod 5… 16 weeks; partial clearance of warts (defined as a reduction in wart area of ≥50%) …

… In vitro, imiquimod has no antiviral or antitumor activity. … of topical imiquimod for the treatment
of external genital warts. Methods: … One hundred eight patients with external genital warts (…

… the safety of imiquimod cream applied topically to anogenital warts in HIV-… anogenital warts,
statistically significant differences in local skin reactions were observed between imiquimod …

… with HPV, although only 1% may have visible genital warts (16, 21). The natural history of
genital warts in … the efficacy and safety of imiquimod for the treatment of external genital warts. …

… This study supports the concept that imiquimod offers patients with anogenital warts a novel
therapy that is self-applied and is safe and effective at treating both the symptoms and the …

… Recurrence of anogenital warts occurred in up to 19… imiquimod. Short-term (≤16 weeks)
clearance rates were similar in men with anogenital warts after treatment with topical imiquimod …